PCV94 THE COST-EFFECTIVENESS OF TITRATION TO GOAL WITH BRAND ROSUVASTATIN COMPARED TO GENERIC SIMVASTATIN IN PATIENTS WITH ELEVATED LOW-DENSITY LIPOPROTEIN CHOLESTEROL- PRIMARY AND SECONDARY PREVENTION IN THE BELGIAN HEALTH CARE SETTING
Oct 1, 2009, 00:00
10.1016/S1098-3015(10)74621-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)74621-0/fulltext
Title :
PCV94 THE COST-EFFECTIVENESS OF TITRATION TO GOAL WITH BRAND ROSUVASTATIN COMPARED TO GENERIC SIMVASTATIN IN PATIENTS WITH ELEVATED LOW-DENSITY LIPOPROTEIN CHOLESTEROL- PRIMARY AND SECONDARY PREVENTION IN THE BELGIAN HEALTH CARE SETTING
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)74621-0&doi=10.1016/S1098-3015(10)74621-0
First page :
Section Title :
Open access? :
No
Section Order :
1